Research progress of long non-coding RNA in autoimmune diseases

[1]

JIAO Lichao, ZHU Yubing, WANG Cancan, FENG Ning, LI Xinxia. Role of histone modifications in regulating immune cell function in diffuse large B-cell lymphoma [J]. Basic & Clinical Medicine, 2026, 46(5): 711-716.

[2]

SHEN Xinyan, GUO Jia, MA Yanni, YU Jia, LIU Siqi. Long non-coding RNA SNHG1 interacting with splicing factors influences erythroid differentiation [J]. Basic & Clinical Medicine, 2026, 46(5): 651-657.

[3]

CHEN Yunhua, LI Di, ZHAO Xiaoyan, CHEN Ming, LI Hongling, ZHAO Chunhua. Knockdown of human-specific lncRNA MEK6-AS1 improves osteogenic differentiation of senescent mesenchymal stem cells [J]. Basic & Clinical Medicine, 2025, 45(5): 568-574.

[4]

ZHOU Changdong, LIN Yang, SUN Kai, TIAN Yuxin. Knockdown of lncRNA UCA1 reduces gemcitabine resistance of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2024, 44(8): 1113-1119.

[5]

ZHOU Yue, TONG Anli. Immune microenvironment of pheochromocytomas and paragangliomas [J]. Basic & Clinical Medicine, 2024, 44(6): 742-747.

[6]

LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua. lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.

[7]

ZHANG Liangliang, ZHAO Chengjin, ZHOU Yuhu, CAO Bo, DUAN Mingming, FENG Yangyang. LncRNA FGD5-AS1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by regulating miR-93-5p/BMP2 axis [J]. Basic & Clinical Medicine, 2023, 43(8): 1179-1185.

[8]

ZHANG Yongmei, ZHANG Zhiming, ZHOU Jie, PAN Zhilan, FENG Liqian, YANG Yan. Expression and clinical significance of LncRNA CBR3-AS1 in multiple myeloma [J]. Basic & Clinical Medicine, 2023, 43(6): 948-952.

[9]

YAO Liuxu, LI Yuhong, JIANG Zongming. Research progress of exosome lncRNA in liquid biopsy of colorectal cancer [J]. Basic & Clinical Medicine, 2023, 43(2): 317-321.

[10]

YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun. LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223 [J]. Basic & Clinical Medicine, 2023, 43(1): 102-109.

[11]

[12]

BAI Bing, ZHANG Hai-fang, YANG Qing-liang, QIN Yue, ZHOU Chen-long, SONG Ge, WANG Ying. Down-regulation of lncRNA RHPN1-AS1 inhibits proliferation and migration of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2022, 42(6): 940-944.

[13]

XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin. Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines [J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.

[14]

GUO Jing, LI Ya-jie, MOU Han-shuang. LncRNA FGD5-AS1 reduces ox-LDL-induced damage of HUVECs by targeting miR-106a-5p [J]. Basic & Clinical Medicine, 2022, 42(5): 768-775.

[15]

LI Zhao-xuan, LUO Yun-ping, CHEN Chong. Establishment and optimization of air-liquid interface method cultured mouse-derived tumor organoids [J]. Basic & Clinical Medicine, 2022, 42(5): 782-787.

PDF